Primary chemotherapy for early and advanced breast cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference46 articles.
1. Breast,1988
2. Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer;Anderson;Br. J. Cancer,1989
3. Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancer;Buzdar;Cancer,1978
4. Combined therapy of stage III adenocarcinoma of the breast;Caceres,1980
5. Inflammatory breast carcinoma treated by radical radiotherapy;Chu;Cancer,1980
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Study protocol: Randomized, open-label, non-inferiority clinical trial for evaluating the clinical and pathological response rates to neoadjuvant hormone therapy and chemotherapy in patients with luminal-subtype breast tumors;Contemporary Clinical Trials Communications;2022-12
2. Pathological response of breast cancer of patients treated by neoadjuvant chemotherapy and correlation with survival. A perspective of real-world pathology;2022-10-24
3. Efficacy of Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in ER-positive Breast Cancer: Results From a Prospective Institutional Database;Clinical Breast Cancer;2019-12
4. Initial Fludeoxyglucose (18F) Positron Emission Tomography-Computed Tomography (FDG-PET/CT) Imaging of Breast Cancer – Correlations with the Primary Tumour and Locoregional Metastases;Polish Journal of Radiology;2017-01-06
5. A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22;SpringerPlus;2015-10-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3